Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
| ▸ | CCR5 | P51681 | 5/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15922997 | 1.00 | ALDH1A1 (0.35) | ALDH1A1TSHRL3MBTL1FAAHCYP2C19 | |
| SCHEMBL15922796 | 0.98 | L3MBTL1 (0.35) | ALDH1A1TSHRL3MBTL1FAAHCYP2C19 | |
| SCHEMBL10544135 | 0.73 | CNR1 (0.33) | TRPV1 | |
| SCHEMBL21866515 | 0.71 | ALDH1A1 (0.34) | ALDH1A1TSHRL3MBTL1FAAHCYP2C19 | |
| SCHEMBL21698564 | 0.60 | FAAH (0.74) | TSHRFAAHCYP2C19TRPV1 | |
| SCHEMBL23040321 | 0.60 | FAAH (0.74) | TSHRFAAHCYP2C19TRPV1 | |
| SCHEMBL25362976 | 0.60 | FAAH (0.74) | TSHRFAAHCYP2C19TRPV1 | |
| SCHEMBL23291808 | 0.60 | FAAH (0.74) | TSHRFAAHCYP2C19TRPV1 | |
| SCHEMBL22654036 | 0.60 | FAAH (0.74) | TSHRFAAHCYP2C19TRPV1 | |
| SCHEMBL21366450 | 0.60 | FAAH (0.74) | TSHRFAAHCYP2C19TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9328126-B2 | Norbornenylhydrocarbylene dihydrocarbylboranes and methods of making the same | PROMERUS, LLC (US) | 2016-05-03 | — | — | US | disclosed |
| US-20150353582-A1 | NORBORNENYLHYDROCARBYLENE DIHYDROCARBYLBORANES AND METHODS OF MAKING THE SAME | PROMERUS, LLC (US) | 2015-12-10 | — | — | US | disclosed |
| WO-2014121008-A1 | NORBORNENYLHYDROCARBYLENE DIHYDROCARBYLBORANES AND METHODS OF MAKING THE SAME | PROMERUS, LLC (US) | 2014-08-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150353582-A1 | NORBORNENYLHYDROCARBYLENE DIHYDROCARBYLBORANES AND METHODS OF MAKING THE SAME | CYP8B1, BDKRB1, CYP1B1 | ALDH1A1 253/4885TSHR 2733/4885L3MBTL1 378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.